Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Maria Buti Ferret

Maria Buti Ferret

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca
Maria Buti Ferret

Maria Buti Ferret

Maria Buti Ferret

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Related news

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Equip projecte ARTEMIs

We study fatty liver and cardiovascular complications with digital twins

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Les Drs. María Martell i Ibane Abasolo

New treatment based on nanoparticles for chronic liver disease

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

See more

Related professionals

Jesús Quintero Bernabeu

Jesús Quintero Bernabeu

Main researcher
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more
Lorena Ramirez Corpas

Lorena Ramirez Corpas

Research technician
Read more
Laura Gisbert Gustemps

Laura Gisbert Gustemps

Psychiatry, Mental Health and Addictions
Read more
Carlos Molina Cateriano

Carlos Molina Cateriano

Head of group
Stroke research
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.